To include your compound in the COVID-19 Resource Center, submit it here.

Shire licenses recombinant immunoglobulin from AB Biosciences

AB Biosciences Inc. (Allston, Mass.) granted Shire plc (LSE:SHP; NASDAQ:SHPG) exclusive, worldwide rights to

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE